Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25529 | 21744131 | Obes Surg | Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25539 | 21734787 | World J Gastroenterol | Adiponectin, a key adipokine in obesity related liver diseases. | 2011 | Details |
| A25540 | 21734391 | Dig Dis | Pathophysiology of non-alcoholic steatohepatitis and basis for treatment. | 2011 | Details |
| A25546 | 21727730 | Saudi J Gastroenterol | Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infection. | 2011 | Details |
| A25550 | 21725512 | J Gastrointestin Liver Dis | Predictive factors for nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD). | 2011 | Details |
| A25551 | 21723839 | J Hepatol | Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. | 2011 | Details |
| A25552 | 21723084 | Presse Med | [Nonalcoholic fatty liver disease]. | 2011 | Details |
| A25559 | 21711426 | Hepatol Res | NASH: A global health problem. | 2011 | Details |
| A25565 | 21707532 | Mini Rev Med Chem | Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA. | 2011 | Details |
| A25569 | 21703998 | Gastroenterology | Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis. | 2011 | Details |
| A25570 | 21703208 | J Hepatol | DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. | 2011 | Details |
| A25571 | 21703200 | J Hepatol | The role of thiazolidinediones in non-alcoholic steatohepatitis - a systematic review and meta analysis. | 2011 | Details |
| A25573 | 21703181 | J Hepatol | Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. | 2011 | Details |
| A25574 | 21703178 | J Hepatol | Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. | 2011 | Details |
| A25582 | 21690266 | J Lipid Res | Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. | 2011 | Details |
| A25585 | 21688564 | Rev Med Chir Soc Med Nat Iasi | [The influence and prevalence of nonalcoholic steatohepatitis in chronic hepatitis B]. | 2011 | Details |
| A25586 | 21688282 | Hepatology | The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. | 2011 | Details |
| A25589 | 21682831 | Hepatol Res | Close correlation of liver stiffness with collagen deposition and presence of myofibroblasts in non-alcoholic fatty liver disease. | 2011 | Details |
| A25591 | 21678341 | Cochrane Database Syst Rev | Weight reduction for non-alcoholic fatty liver disease. | 2011 | Details |
| A25593 | 21675270 | Ter Arkh | [Clinical significance of intravital morphological investigation of the liver]. | 2011 | Details |
| A25594 | 21674556 | Hepatology | Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis. | 2011 | Details |
| A25596 | 21674175 | Dig Dis Sci | Serum immunoglobulin a concentration is an independent predictor of liver fibrosis in nonalcoholic steatohepatitis before the cirrhotic stage. | 2011 | Details |
| A25601 | 21664615 | Atherosclerosis | Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease. | 2011 | Details |
| A25605 | 21659620 | Am J Physiol Gastrointest Liver Physiol | Role of integrins in fibrosing liver diseases. | 2011 | Details |
| A25610 | 21649947 | Ned Tijdschr Geneeskd | [Treatment of non-alcoholic fatty liver disease]. | 2011 | Details |
| A25620 | 21634051 | Clin Res Hepatol Gastroenterol | Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease. | 2011 | Details |
| A25622 | 21633658 | World J Gastroenterol | microRNAs: fad or future of liver disease. | 2011 | Details |
| A25627 | 21629127 | J Pediatr Gastroenterol Nutr | Mechanisms of lipotoxicity in NAFLD and clinical implications. | 2011 | Details |
| A25631 | 21623852 | Aliment Pharmacol Ther | Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. | 2011 | Details |
| A25634 | 21620948 | Toxicol In Vitro | Cellular glutathione in fatty liver in vitro models. | 2011 | Details |
| A25640 | 21612324 | Drug Metab Rev | Drug metabolism alterations in nonalcoholic fatty liver disease. | 2011 | Details |
| A25646 | 21600867 | Clin Res Hepatol Gastroenterol | Diagnostic challenges of nonalcoholic fatty liver disease (NAFLD) in children of normal weight. | 2011 | Details |
| A25669 | 21563648 | Acta Gastroenterol Belg | High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registry. | 2011 | Details |
| A25678 | 21557768 | J Gastroenterol Hepatol | Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath test. | 2011 | Details |
| A25680 | 21557024 | Hepatol Int | Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network. | 2011 | Details |
| A25681 | 21556019 | Nat Rev Endocrinol | Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. | 2011 | Details |
| A25683 | 21549113 | Eur J Pharmacol | Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease. | 2011 | Details |
| A25691 | 21538280 | Semin Liver Dis | Genetics of alcoholic and nonalcoholic fatty liver disease. | 2011 | Details |
| A25701 | 21521847 | JAMA | Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. | 2011 | Details |
| A25709 | 21519163 | Korean J Gastroenterol | [Association among histopathology, clinical manifestation, and ultrasonographic grades in pediatric non-alcoholic fatty liver disease]. | 2011 | Details |
| A25713 | 21517924 | Aliment Pharmacol Ther | Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. | 2011 | Details |
| A25715 | 21514287 | Clin Chim Acta | The role of oxidative stress in non-alcoholic steatohepatitis. | 2011 | Details |
| A25716 | 21513939 | Atherosclerosis | Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25729 | 21499110 | Eur J Gastroenterol Hepatol | Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity. | 2011 | Details |
| A25731 | 21498305 | Acta Radiol | Unenhanced fat fraction ratios obtained by MR and enhanced T2* values with liver-specific MR contrast agents for diagnosis of non-alcoholic steatohepatitis in rats. | 2011 | Details |
| A25733 | 21497743 | Best Pract Res Clin Gastroenterol | Liver fibrosis in paediatric liver diseases. | 2011 | Details |
| A25734 | 21497741 | Best Pract Res Clin Gastroenterol | Fibrosis in alcoholic and nonalcoholic steatohepatitis. | 2011 | Details |
| A25739 | 21492876 | J Surg Res | The effect of hepatic ischemia reperfusion injury in a murine model of nonalcoholic steatohepatitis. | 2011 | Details |
| A25747 | 21486894 | J Clin Pathol | Participation of bile ductular cells in the pathological progression of non-alcoholic fatty liver disease. | 2011 | Details |
| A25748 | 21484137 | Hepatol Int | Non-cirrhotic portal fibrosis related end stage liver disease in adults: evaluation from a study on living donor liver transplant recipients. | 2011 | Details |
| A25754 | 21478462 | Diabetes Care | Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. | 2011 | Details |
| A25755 | 21477300 | Lipids Health Dis | Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25758 | 21476920 | Expert Rev Gastroenterol Hepatol | Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. | 2011 | Details |
| A25759 | 21476919 | Expert Rev Gastroenterol Hepatol | Microsomal triglyceride transfer protein and nonalcoholic fatty liver disease. | 2011 | Details |
| A25761 | 21476917 | Expert Rev Gastroenterol Hepatol | Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective. | 2011 | Details |
| A25764 | 21476914 | Expert Rev Gastroenterol Hepatol | Inflammation in nonalcoholic steatohepatitis. | 2011 | Details |
| A25765 | 21476913 | Expert Rev Gastroenterol Hepatol | Fibrogenesis in nonalcoholic steatohepatitis. | 2011 | Details |
| A25781 | 21463337 | Alcohol Clin Exp Res | A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis. | 2011 | Details |
| A25782 | 21460032 | Radiology | Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. | 2011 | Details |
| A25786 | 21457446 | Liver Int | Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. | 2011 | Details |
| A25787 | 21457442 | Liver Int | Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors. | 2011 | Details |
| A25791 | 21452138 | Ther Umsch | [Non-alcoholic steatohepatitis - from NAFLD to MAFLD]. | 2011 | Details |
| A25793 | 21451413 | Curr Opin Gastroenterol | Genetics in liver disease: new concepts. | 2011 | Details |
| A25794 | 21449949 | Diabetes Obes Metab | Current therapeutic strategies in non-alcoholic fatty liver disease. | 2011 | Details |
| A25797 | 22813407 | Diabetes Metab Syndr | Association of nonalcoholic fatty liver disease with metabolic syndrome in Indian population. | 2012 | Details |
| A25802 | 21442288 | Virchows Arch | Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. | 2011 | Details |
| A25814 | 21431854 | Curr Diab Rep | Why does NAFLD predict type 2 diabetes? | 2011 | Details |
| A25826 | 21423719 | PLoS Genet | Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. | 2011 | Details |
| A25838 | 21410952 | J Inflamm (Lond) | Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice. | 2011 | Details |
| A25841 | 21407274 | Nefrologia | Management of HCV infection in chronic kidney disease. | 2011 | Details |
| A25845 | 21401612 | J Pharm Pharmacol | Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis. | 2011 | Details |
| A25854 | 21389796 | Eur J Gastroenterol Hepatol | Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis. | 2010 | Details |
| A25861 | 21382165 | Liver Int | A novel and comprehensive mouse model of human non-alcoholic steatohepatitis with the full range of dysmetabolic and histological abnormalities induced by gold thioglucose and a high-fat diet. | 2011 | Details |
| A25862 | 21382157 | Liver Int | Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease. | 2011 | Details |
| A25864 | 21381068 | Hepatology | Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. | 2011 | Details |
| A25865 | 21378763 | Am J Gastroenterol | Editorial: Exercise for NAFLD: does intensity matter? | 2011 | Details |
| A25867 | 21376261 | Arch Med Res | Circulating levels of vascular endothelial growth factor A and its soluble receptor in patients with biopsy-proven nonalcoholic fatty liver disease. | 2011 | Details |
| A25871 | 21373917 | Internist (Berl) | [Nonalcoholic steatohepatitis. Predictor and consequence of diabetes]. | 2011 | Details |
| A25872 | 21372165 | Am J Physiol Gastrointest Liver Physiol | Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats. | 2011 | Details |
| A25878 | 21360720 | Hepatology | Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. | 2011 | Details |
| A25882 | 21356258 | J Hepatol | Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome. | 2011 | Details |
| A25884 | 21354232 | J Hepatol | Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. | 2011 | Details |
| A25886 | 21353887 | Vitam Horm | Activin A in nonalcoholic fatty liver disease. | 2011 | Details |
| A25890 | 21350190 | Am J Physiol Gastrointest Liver Physiol | Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model. | 2011 | Details |
| A25891 | 21350183 | Am J Physiol Gastrointest Liver Physiol | Obesity, diabetes mellitus, and liver fibrosis. | 2011 | Details |
| A25898 | 21345221 | Diabetol Metab Syndr | New clinical score to diagnose nonalcoholic steatohepatitis in obese patients. | 2011 | Details |
| A25906 | 21338989 | Atherosclerosis | Olmesartan severely weakened the development of NASH in an animal model of hypercholesterolemia. | 2011 | Details |
| A25909 | 21336425 | Nutr Hosp | Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents? | 2011 | Details |
| A25910 | 21335212 | Transplant Proc | Metabolic syndrome in transplant patients: an academic or a health burden? | 2011 | Details |
| A25912 | 21333494 | Nutrition | Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis. | 2011 | Details |
| A25913 | 21332546 | J Gastroenterol Hepatol | Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population? | 2011 | Details |
| A25919 | 21327921 | Dig Dis Sci | Correlation analysis between gene expression profile of rat liver tissues and high-fat emulsion-induced nonalcoholic fatty liver. | 2011 | Details |
| A25923 | 21324757 | Dig Liver Dis | High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis. | 2011 | Details |
| A25924 | 21320639 | Clin Gastroenterol Hepatol | Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. | 2011 | Details |
| A25926 | 21319202 | Hepatology | Nuclear receptors in liver disease. | 2011 | Details |
| A25932 | 21303916 | Gut | Non-alcoholic fatty liver disease: what's new under the microscope? | 2011 | Details |
| A25935 | 21301010 | Ann Hepatol | Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease. | 2011 | Details |
| A25936 | 21301007 | Ann Hepatol | Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile. | 2011 | Details |
| A25938 | 21299150 | Acta Gastroenterol Belg | Dietary lipids and NAFLD: suggestions for improved nutrition. | 2011 | Details |
| A25943 | 21284669 | Alcohol Clin Exp Res | Genetics of liver injury and fibrosis. | 2011 | Details |